NUEVOLUTION A/S
CVR: 26029708
NUEVOLUTION A/S is currently facing financial challenges, as evidenced by its negative profit margins over the past three years, culminating in a loss of 18.4 million DKK in 2024 despite a revenue increase to 118.4 million DKK. The company has seen fluctuating revenues, peaking at 162.3 million DKK in 2021, but has since experienced a downward trend in profitability, with equity decreasing from 132.5 million DKK in 2021 to 49.7 million DKK in 2024. Key concerns include the significant losses and declining equity, which may impact its operational stability and growth potential within the competitive research and experimental development sector. Overall, NUEVOLUTION A/S is navigating a challenging financial landscape, necessitating strategic adjustments to improve its profitability and equity position.
AI-generated summary
Overview
Details
Purpose
Selskabets formål er at frembringe og kommereialisere teknologier til fremstilling af stoffer til brug indenfor lægemiddelindustrien ved screening af ikke-biologiske polymerer og lav-molekylære stoffer samt hermed naturlige forbundet virksomhed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 118.4 mio. | -18.4 mio. | 173.8 mio. | 49.7 mio. | 77 | |
History
Ownership
Management
Directors
Board
Founders
Production units (2)
Similar companies
Companies in the same industry and area